SuperSonic Imagine appoints Michèle Lesieur as Chief Executive Officer and President
Regulatory News:
SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), the highly-innovative ultrasound company, today
announces the appointment of Michèle Lesieur as President and CEO, thus replacing Bernard Doorenbos.
Michael Brock, Chairman of the Supervisory Board, says: “SuperSonic Imagine’s Supervisory Board is enthusiastic about Michèle
Lesieur becoming the Company’s President and CEO. Her expertise, her leadership and her significant experience in international
healthcare companies made her the best candidate to run SuperSonic Imagine, thus replacing Bernard Doorenbos, who was interim
President and CEO. Indeed, we would like to thank Bernard for his contribution. Under Michèle’s experienced leadership, the Company
will continue to implement its strategic plan, which consists in moving forward on its various markets by capitalizing on the
highly-innovative nature of its Aixplorer® ultrasound platform, launching new innovative features and
products and developing new fruitful partnerships. Along with our dedicated employees and a strong leadership team now headed by
Michèle Lesieur, the Supervisory Board is confident that the scene is set for resuming a strong development track going
forward.”
Michèle Lesieur held various positions within the Philips group at domestic and international level. Over the last five years,
she was the President of Philips France and Head of Philips Healthcare in France. Before that, Michèle spent five years in charge
of Sales & Marketing for the group’s medical imaging systems at international level, after having spent six years heading the
Philips Medical Systems division in France. Michèle Lesieur has substantial expertise in the consumer electronics and telecoms
sectors, having been in turn Marketing Director of Philips Business Electronics France and Managing Director of a Philips Business
Electronics department responsible for the international sales policy and development strategy. With a Masters degree in Physics
from Paris XI University and a postgraduate degree in Optical Transmission and Signal Processing from the Institut Supérieur
d’Optique, Michèle began her career in laboratories with the aim of developing video communication optical transmission
systems.
Michèle Lesieur concludes: “I am proud to have this opportunity to provide SuperSonic Imagine with my experience and dynamism
by becoming the Company’s new CEO. The unwavering commitment, cohesion and talent of its teams have led it to now possess
ultrasound technology and products whose highly-innovative aspect provides practitioners with an opportunity to better diagnose and
treat liver and breast pathologies in patients. The Company has solid assets, and I firmly believe that we will be able to rapidly
develop its established activity in France and abroad.”
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The
company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that
can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this
unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™
Elastography (SWE™), UltraFast™ Doppler, Angio PL.U.S – Planewave UltraSensitive™ Imaging and more recently TriVu. ShearWave
Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and
non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased
tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients
with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam,
providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio
PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while
maintaining exceptional 2D imaging. SuperSonic Imagine has been granted regulatory clearances for the commercialization of
Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI. For more
information about SuperSonic Imagine, please go to www.supersonicimagine.com.
Contact information:
SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
emmanuelle.vella@supersonicimagine.com
+33 4 86 79 03 27
or
NewCap
Investor Relations – EU
Pierre Laurent / Florent Alba supersonicimagine@newcap.fr
+33144719855
or
Pascale Communication
Media Relations - US
Amy Phillips
amy@pascalecommunications.com
+1 412 327 9499
View source version on businesswire.com: http://www.businesswire.com/news/home/20161124005267/en/